DiaCoating GmbH

DiaCoating GmbH is an Austrian company based in Wattens that develops and manufactures nanocrystalline diamond (NCD) coatings and tailored nano-diamond particles for medical implant and bone-substitute applications. According to its official website, the company's core technology is the deposition of nanocrystalline diamond layers onto implant surfaces and the functionalization of nano-diamond particles to improve biocompatibility, hydrophilicity, healing (osseointegration and soft-tissue integration), corrosion protection, passivation of metal ions, and antibacterial surface performance. The company presents itself as a manufacturer and product-development partner in the field of tailored implant surfaces based on nano-based coating technology. The company's NCD coatings are used in dental implants and hip implants. Its nano-diamond particles are used to modify bone-substitute materials based on ceramics and polymers, with the aim of improving vascularization and the healing of large bone defects. DiaCoating's work is embedded in publicly funded and collaborative research: it references the Laura Bassi Centre DiaLife (www.dialife.org) for the development and production of new implant surfaces for improved bone and soft-tissue healing, simple stable functionalization, and antibacterial surfaces; and the VascuBone project (www.vascubone.fraunhofer.eu) for the development and production of tailored bone-salt materials based on nano-diamond particles modified with growth factors for large bone defects, so-called "critical size defects" (CSD). Cooperation partners named on the website include CarbonCompetence GmbH (www.carboncompetence.com) and the University of Bergen with Prof. Kamal Mustafa, in the ongoing project 3DPRENT (www.tissueengineering.no). The company is registered at c/o Werkstätte Wattens, Weisstraße 9, 6112 Wattens, Austria. Its contact points are Dr. Doris Steinmüller-Nethl, CSO, and Mag. Armin Partl, CEO. DiaCoating is a private company and does not appear to be listed on a stock exchange. Its positioning is that of a specialized B2B technology and materials partner for the medical-device and tissue-engineering industries rather than a consumer-facing brand.

DiaCoating GmbH is an Austrian technology company located in Wattens, Tyrol, operating from the Werkstätte Wattens address. The company was established to commercialize nanocrystalline diamond (NCD) coating technology and nano-diamond particle functionalization for medical applications. Its official website describes a focus on the development and manufacture of new implant surfaces that improve healing in bone and soft tissue, enable simple and stable functionalization, and provide antibacterial surface properties. The company's technology has been advanced through participation in publicly funded research and collaborative projects. It cites the Laura Bassi Centre DiaLife (www.dialife.org) as a reference for the development and production of new implant surfaces. It also cites the VascuBone project (www.vascubone.fraunhofer.eu), which developed and produced tailored bone-salt materials based on nano-diamond particles modified with growth factors for large bone defects, known as "critical size defects" (CSD). DiaCoating lists cooperation partners including CarbonCompetence GmbH (www.carboncompetence.com) and the University of Bergen, where Prof. Kamal Mustafa leads an ongoing project called 3DPRENT (www.tissueengineering.no). The company's applications include NCD coatings for dental implants and hip implants, and nano-diamond particles for modifying ceramic- and polymer-based bone-substitute materials to improve vascularization and healing of large bone defects. The company is privately held and is not known to be listed on a stock exchange. Its leadership includes Dr. Doris Steinmüller-Nethl as CSO and Mag. Armin Partl as CEO.

Specialized B2B developer and manufacturer of nano-based implant surface technologies and nano-diamond materials for medical implants and bone regeneration.

• Nanocrystalline diamond (NCD) coatings

  Coatings applied to implant surfaces to improve biocompatibility, hydrophilicity, osseointegration, soft-tissue healing, corrosion protection, passivation of metal ions, and antibacterial performance.

• Tailored nano-diamond particles

  Particles used to modify ceramic- and polymer-based bone-substitute materials to improve vascularization and healing of large bone defects.

1. 1DiaCoating GmbH official websitediacoating.com
2. 2DiaCoating GmbH - Wikidatawikidata.org